Exogenous melatonin for sleep problems in individuals with intellectual disability: a meta-analysis.
about
Clinical uses of melatonin in pediatricsPrader-Willi, Angelman, and 15q11-q13 Duplication SyndromesCircadian rhythm abnormalitiesMelatonin Treatment in Children with Developmental DisabilitiesMelatonin improves sleep in children with epilepsy: a randomized, double-blind, crossover study.Autism as a disorder of biological and behavioral rhythms: toward new therapeutic perspectivesMutation screening of ASMT, the last enzyme of the melatonin pathway, in a large sample of patients with intellectual disabilityAdvances in the research of melatonin in autism spectrum disorders: literature review and new perspectivesMelatonin in Tuberous Sclerosis Complex Analysis Using Modern Mathematical Modeling MethodsSleep in Neurodevelopmental Disorders.British Association for Psychopharmacology consensus statement on evidence-based treatment of insomnia, parasomnias and circadian rhythm disorders.Characterizing sleep disorders of adults with tuberous sclerosis complex: a questionnaire-based study and review.Melatonin for sleep problems in children with neurodevelopmental disorders: randomised double masked placebo controlled trialDissolution of Intact, Divided and Crushed Circadin Tablets: Prolonged vs. Immediate Release of MelatoninMelatonin improves sleep quality in hemodialysis patients.Melatonin in Youth: N-of-1 trials in a stimulant-treated ADHD Population (MYNAP): study protocol for a randomized controlled trialChronicity of sleep problems in children with chronic illness: a longitudinal population-based study.Developmental Programming of Adult Disease: Reprogramming by Melatonin?Systematic Reviews of the Health or Health care of People with Intellectual Disabilities: A Systematic Review to Identify Gaps in the Evidence Base.Behavioural interventions for sleep problems in people with an intellectual disability: a systematic review and meta-analysis of single case and group studies.Angelman syndrome: Current and emerging therapies in 2016.Analysis on nutritional risk screening and influencing factors of hospitalized patients in central urban area.Sleep in Autism Spectrum Disorders.Unmet clinical needs and burden in Angelman syndrome: a review of the literature.Pharmacological therapies for Angelman syndrome.Melatonin and Angelman Syndrome: Implications and Mathematical Model of Diurnal Secretion.Practitioner Review: Treatment of chronic insomnia in children and adolescents with neurodevelopmental disabilities.European guideline for the diagnosis and treatment of insomnia.Analysis of Different Melatonin Secretion Patterns in Children With Sleep Disorders: Melatonin Secretion Patterns in Children.Melatonin for sleep disturbance in children with neurodevelopmental disorders: prospective observational naturalistic study.Melatonin and health: an umbrella review of health outcomes and biological mechanisms of action.Central sleep apnea: does stabilizing sleep improve it?CYP1A2 polymorphisms in slow melatonin metabolisers: a possible relationship with autism spectrum disorder?Effect of melatonin on seizure frequency in intractable epilepsy: a pilot study.
P2860
Q21296744-24F671DE-E193-46E0-90BE-028E12EAFCEAQ26827423-B28E413E-B15F-498B-A100-224FDA049A08Q26861877-D34CCA12-507B-4657-8732-BA12B35084C5Q27012836-27326AE4-008A-48F1-AECB-A6D6AFECB05CQ27303807-4442060F-751D-431A-AC1A-F4FB89FE362CQ28080719-CDACDE52-BC00-475A-B405-AE90FB9F698DQ28386102-B507EB2D-7B6D-474E-9284-805EE7F95C19Q28661706-9F34C03F-C683-4D6C-B0AD-8954B891EBEBQ33655732-ADDD90EA-B936-4B29-A144-250E99585836Q33655855-B47385F0-713E-4592-8309-D8D82E4D7F5CQ34135759-487D6389-8596-4DDD-90C9-3E6BB3A35A22Q36226150-6B2851C5-C27A-4021-9442-A701D52980E4Q36372805-136AE5D0-1F54-4796-9A43-518BF7F7AFE2Q36735320-6334CFEA-7521-4E14-BD7D-08E2555E6E84Q37091140-32DF9AC3-8393-429E-92CE-3634B19DDC87Q37138835-A014848B-3459-4835-B55E-74A30D63A634Q37348984-7D4B73A8-FD1F-4FDD-9C8F-E18C733E854AQ37691012-024D27EB-B93D-4BF3-BA86-35C0E571DE10Q38397364-046C0279-3E97-48FE-926E-7A379A3E6A18Q38764691-2D33D4A8-D52A-49FF-91F3-BAD231179819Q39012491-C3448472-AACB-4F29-A6D0-E72DFDBF6BF1Q40493466-101BE02E-F34C-4502-94FF-05686BBD67B2Q41486105-B156117C-8333-479A-B4BE-9EF13823BF91Q42689806-35A03A6D-331E-4195-92A5-D9455D56AFF5Q46368852-5D8EF02D-9606-48F8-9623-564FD36FE200Q47555093-264372E1-4EE7-4724-98A0-F066AAF08211Q47619565-0736AEBF-12EE-40E5-A117-9E09AB3F0759Q47628865-ACADB38C-5DF1-41E7-BAD2-DA5A621F71B4Q47685588-6A38C8FB-38E8-475A-946C-C7BFEC1309BCQ47975631-32773C8F-4A00-44AF-928C-67D79CB18395Q48109920-66B38C23-76C2-4DF3-ACE8-938BB7818DC3Q48207652-0AB3F263-196C-4A5F-A64D-8C536F8B6258Q48232008-A0A31044-5B08-41A4-8D19-750289531395Q48256192-D3AD5EDC-C117-4E3A-886A-D301E68E7BCA
P2860
Exogenous melatonin for sleep problems in individuals with intellectual disability: a meta-analysis.
description
2009 nî lūn-bûn
@nan
2009 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Exogenous melatonin for sleep ...... l disability: a meta-analysis.
@ast
Exogenous melatonin for sleep ...... l disability: a meta-analysis.
@en
Exogenous melatonin for sleep ...... l disability: a meta-analysis.
@nl
type
label
Exogenous melatonin for sleep ...... l disability: a meta-analysis.
@ast
Exogenous melatonin for sleep ...... l disability: a meta-analysis.
@en
Exogenous melatonin for sleep ...... l disability: a meta-analysis.
@nl
prefLabel
Exogenous melatonin for sleep ...... l disability: a meta-analysis.
@ast
Exogenous melatonin for sleep ...... l disability: a meta-analysis.
@en
Exogenous melatonin for sleep ...... l disability: a meta-analysis.
@nl
P2093
P921
P1476
Exogenous melatonin for sleep ...... l disability: a meta-analysis.
@en
P2093
Hubert Korzilius
Leopold M G Curfs
Marcel G Smits
Robert Didden
P2860
P304
P356
10.1111/J.1469-8749.2008.03244.X
P577
2009-05-01T00:00:00Z